Morgan Stanley China
Shanghaimorganstanley.com
Overview
Morgan Stanley China represents the Chinese operations of the global financial services firm, providing investment banking, securities, asset management, and private equity services. Its private equity investment activities are primarily conducted through Morgan Stanley Private Equity Asia (MSPEA), which focuses on privately negotiated minority investments and control buyouts in growth-oriented companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Beijing Biosis Healing Biological Technology | Jul 2023 | Series D | Co-investor |
| Kaadas Group | Mar 2022 | Series C | Co-investor |
| KNX Human Resource Solutions | May 2017 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
